Light-activated PEG deshielding core–shell nanoparticles for enhanced chemo-photodynamic combination therapy
Source abstract
Abstract
Chemo-photodynamic combination therapy has attracted great attention as a promising cancer treatment strategy. However, the therapeutic efficacy has been limited by the low selectivity and penetration of therapeutic agents into the tumor. PEGylation is an effective strategy to enhance the stability and circulation times of nanoparticles, which improves the bioavailability of encapsulated drugs. However, such PEGylation nanomedicines also decrease cellular uptake efficiency. Herein, we developed a smart nano-drug delivery system with PEG deshielding and charge reversal performance triggered by external light irradiation, which can not only enhance tumor selectivity and tumor penetration but also combine photodynamic therapy and chemotherapy for better tumor treatment effects, contributed by the use of core-shell nanoparticles with positively charged complex Pt(IV) prodrugs and photosensitizers.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China
State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing 100029, China
Funding
National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities
References (40)
Show source-provided references
1. Luo · Adv. Sci. · 2017 · 4 · 160010610.1002/advs.201600106 ↗
2. Luby · Angew. Chem., Int. Ed. · 2019 · 58 · 255810.1002/anie.201805246 ↗
3. He · Nat. Commun. · 2016 · 7 · 1249910.1038/ncomms12499 ↗
4. Wei · ACS Nano · 2021 · 15 · 542810.1021/acsnano.1c00076 ↗
5. Huang · Acta Biomater. · 2023 · 160 · 19810.1016/j.actbio.2023.02.012 ↗
6. Zhang · Nano Today · 2023 · 50 · 10182410.1016/j.nantod.2023.101824 ↗
7. Xiong · Small Methods · 2022 · 6 · e220037910.1002/smtd.202200379 ↗
8. Zhen · Biomaterials · 2019 · 218 · 11933010.1016/j.biomaterials.2019.119330 ↗
9. Karges · Angew. Chem., Int. Ed. · 2020 · 59 · 706910.1002/anie.201916400 ↗
10. Choi · ACS Nano · 2021 · 15 · 1208610.1021/acsnano.1c03416 ↗
11. Zhang · ACS Nano · 2021 · 16 · 142110.1021/acsnano.1c09555 ↗
12. Wan · Biomaterials · 2018 · 155 · 2510.1016/j.biomaterials.2017.11.002 ↗
13. Li · J. Nanobiotechnol. · 2021 · 19 · 14010.1186/s12951-021-00876-7 ↗
14. Wang · Nat. Biomed. Eng. · 2021 · 5 · 104810.1038/s41551-021-00728-7 ↗
15. Fu · Angew. Chem., Int. Ed. · 2020 · 59 · 2154610.1002/anie.202005612 ↗
16. Belli · Cancer Treat. Rev. · 2018 · 65 · 2210.1016/j.ctrv.2018.02.004 ↗
17. Bejarano · Cancer Discovery · 2021 · 11 · 93310.1158/2159-8290.CD-20-1808 ↗
18. Tang · Adv. Mater. · 2022 · 34 · e220382010.1002/adma.202203820 ↗
19. Wang · ACS Nano · 2017 · 11 · 222710.1021/acsnano.6b08731 ↗
20. Li · Adv. Mater. · 2018 · 30 · e180280810.1002/adma.201802808 ↗
21. Chen · Adv. Mater. · 2017 · 29 · 170117010.1002/adma.201701170 ↗
22. Kang · J. Mater. Chem. B · 2019 · 7 · 334610.1039/C9TB00155G ↗
23. Xu · Adv. Mater. · 2020 · 32 · e190674510.1002/adma.201906745 ↗
24. Su · Theranostics · 2015 · 5 · 123310.7150/thno.12843 ↗
25. Xiong · Biomaterials · 2020 · 245 · 11984010.1016/j.biomaterials.2020.119840 ↗
26. Li · Adv. Sci. · 2020 · 8 · 200258910.1002/advs.202002589 ↗
27. Qi · Front. Chem. · 2021 · 9 · 77568210.3389/fchem.2021.775682 ↗
28. Zhang · J. Nanobiotechnol. · 2022 · 20 · 3110.1186/s12951-021-01221-8 ↗
29. Liu · Nat. Commun. · 2021 · 12 · 572610.1038/s41467-021-26052-x ↗
30. Zhang · Chem. Sci. · 2018 · 9 · 526010.1039/C8SC01828F ↗
31. Chen · Chem. Sci. · 2019 · 10 · 935110.1039/C9SC03781K ↗
32. Hung · Theranostics · 2016 · 6 · 30210.7150/thno.13686 ↗
33. Thurston · J. Clin. Invest. · 1998 · 101 · 140110.1172/JCI965 ↗
34. Alexis · Mol. Pharm. · 2008 · 5 · 50510.1021/mp800051m ↗
35. Komarova · Annu. Rev. Physiol. · 2010 · 72 · 46310.1146/annurev-physiol-021909-135833 ↗
36. Teesalu · Proc. Natl. Acad. Sci. U. S. A. · 2009 · 106 · 1615710.1073/pnas.0908201106 ↗
37. Yang · Macromol. Rapid. Commun. · 2020 · 41 · e200010610.1002/marc.202000106 ↗
38. Yap · Macromol. Rapid. Commun. · 2020 · 41 · e200023610.1002/marc.202000236 ↗
39. Gou · Acta Biomater. · 2017 · 62 · 15710.1016/j.actbio.2017.08.025 ↗
40. Wei · ACS Nano · 2020 · 14 · 1698410.1021/acsnano.0c06190 ↗